FERRARESE, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 46.218
EU - Europa 26.429
AS - Asia 16.251
SA - Sud America 1.843
AF - Africa 196
Continente sconosciuto - Info sul continente non disponibili 63
OC - Oceania 46
AN - Antartide 1
Totale 91.047
Nazione #
US - Stati Uniti d'America 45.281
IT - Italia 6.260
SG - Singapore 4.938
RU - Federazione Russa 4.119
DE - Germania 3.978
HK - Hong Kong 3.701
CN - Cina 3.549
SE - Svezia 3.116
IE - Irlanda 2.432
UA - Ucraina 1.990
VN - Vietnam 1.968
BR - Brasile 1.603
GB - Regno Unito 1.333
CA - Canada 796
FI - Finlandia 787
FR - Francia 589
AT - Austria 539
IN - India 491
NL - Olanda 324
TR - Turchia 305
KR - Corea 262
ID - Indonesia 229
DK - Danimarca 194
BE - Belgio 185
PL - Polonia 167
BD - Bangladesh 151
JP - Giappone 114
IQ - Iraq 105
IR - Iran 89
ES - Italia 82
MX - Messico 81
CZ - Repubblica Ceca 72
ZA - Sudafrica 65
AR - Argentina 59
EU - Europa 55
PK - Pakistan 53
CH - Svizzera 46
UZ - Uzbekistan 40
AU - Australia 39
SA - Arabia Saudita 36
EC - Ecuador 35
VE - Venezuela 35
PT - Portogallo 28
KE - Kenya 26
IL - Israele 25
LT - Lituania 25
CL - Cile 24
CO - Colombia 24
EG - Egitto 24
GR - Grecia 24
RO - Romania 22
MA - Marocco 21
PE - Perù 21
AE - Emirati Arabi Uniti 19
JM - Giamaica 19
PY - Paraguay 18
NO - Norvegia 17
PH - Filippine 17
UY - Uruguay 17
AL - Albania 15
AZ - Azerbaigian 14
BG - Bulgaria 14
NP - Nepal 14
TN - Tunisia 14
OM - Oman 13
JO - Giordania 12
HU - Ungheria 11
KZ - Kazakistan 11
LV - Lettonia 11
MY - Malesia 10
PA - Panama 10
TW - Taiwan 10
ET - Etiopia 9
KG - Kirghizistan 9
LB - Libano 8
NI - Nicaragua 8
TH - Thailandia 8
BH - Bahrain 7
EE - Estonia 7
NZ - Nuova Zelanda 7
PS - Palestinian Territory 7
A2 - ???statistics.table.value.countryCode.A2??? 6
BO - Bolivia 6
HN - Honduras 6
LU - Lussemburgo 6
MD - Moldavia 6
SK - Slovacchia (Repubblica Slovacca) 6
AM - Armenia 5
CI - Costa d'Avorio 5
CR - Costa Rica 5
DZ - Algeria 5
MN - Mongolia 5
MT - Malta 5
MU - Mauritius 5
TT - Trinidad e Tobago 5
BB - Barbados 4
BY - Bielorussia 4
GE - Georgia 4
KW - Kuwait 4
SC - Seychelles 4
Totale 90.989
Città #
Ann Arbor 8.919
Woodbridge 4.249
Hong Kong 3.661
Ashburn 3.341
Chandler 3.100
Singapore 2.927
Fairfield 2.819
Houston 2.669
Dublin 2.341
Frankfurt am Main 2.204
Jacksonville 2.172
Wilmington 1.829
Milan 1.486
Santa Clara 1.439
Dearborn 1.368
Seattle 1.201
New York 1.188
Cambridge 999
Princeton 974
Nanjing 558
Hanoi 545
Shanghai 504
Ho Chi Minh City 467
Vienna 466
Beijing 438
Lachine 375
Lawrence 368
Munich 368
Moscow 356
Boardman 353
Altamura 324
Helsinki 251
Seoul 225
Los Angeles 219
Jakarta 216
Dong Ket 208
Hefei 206
San Diego 187
Rome 186
Hangzhou 185
Nanchang 184
Council Bluffs 181
Guangzhou 181
Brussels 175
Shenyang 173
Andover 156
Toronto 140
Fremont 139
São Paulo 137
Nuremberg 131
London 125
Hebei 124
Mountain View 123
Falls Church 118
Ottawa 115
Dallas 112
Tianjin 110
Changsha 102
Jinan 97
The Dalles 97
Pune 87
Chicago 86
Columbus 84
Jiaxing 82
Turku 80
Ningbo 76
Lissone 75
Kraków 74
Grafing 72
Zhengzhou 72
Monza 70
Turin 67
Da Nang 62
Detroit 61
Huizen 61
Norwalk 61
Lappeenranta 60
Brooklyn 56
Rio de Janeiro 56
Warsaw 50
Naples 49
Brno 47
Kunming 47
Edmonton 46
Pisa 44
Belo Horizonte 43
Dhaka 43
Philadelphia 43
Redmond 43
Quận Bình Thạnh 42
Tokyo 42
Washington 42
Carate Brianza 41
Düsseldorf 41
Florence 41
Bologna 40
San Mateo 40
Como 39
Amsterdam 38
Nürnberg 38
Totale 60.852
Nome #
The hand pronation phenomenon: a franco-german tale 1.748
Harmonization of sensorimotor deficit assessment in a registered multicentre pre-clinical randomized controlled trial using two models of ischemic stroke 952
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 510
Using global team science to identify genetic parkinson's disease worldwide 441
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 431
Assessing early to late stage dementia: the TSI and BANS-S scales in the nursing-home 429
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 417
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 409
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases 392
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 379
Brand new norms for a good old test: Northern Italy normative study of MiniMental State Examination 374
Cognitive assessment of severe dementia: The test for severe impairment (TSI) 370
Substrate-induced modulation of glutamate uptake in human platelets 366
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 358
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 356
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy 350
A Metabolic Imaging Study of Lexical and Phonological Naming Errors in Alzheimer Disease 349
Increased plasma glutamate in stroke patients might be linked to altered platelet release and uptake 345
Malattie del Sistema Nervoso 342
Cognitive reserve maps the core loci of neurodegeneration in corticobasal degeneration 340
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 337
Decreased whole-blood global DNA methylation is related to serum hormones in anorexia nervosa adolescents. 329
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 327
Paradoxical Increase of plasma vitamin B12 and folates with disease severity in anorexia nervosa 323
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 323
Oxidative stress and altered mitochondrial dynamics in neurodegenerative processes 318
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 312
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 306
Irisin and BDNF serum levels and behavioral disturbances in Alzheimer's disease 302
Physical anhedonia in Parkinson's disease 301
The role of clinical and neuroimaging features in the diagnosis of CADASIL 301
null 296
Clinical pregenetic screening for stroke monogenic diseases: Results from lombardia GENS registry 292
Ischemic Conditions Affect Rerouting of Tau Protein Levels: Evidences for Alteration in Tau Processing and Secretion in Hippocampal Neurons 290
Can Signaling Molecules in Fibroblasts Detect Prodromal Alzheimer's Disease? 290
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 287
Incidence and predictors of acute symptomatic seizures after stroke 286
Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment 282
The one-carbon metabolism in anorexia nervosa of the restrictive type 280
Serum DBI and biomarkers of neuroinflammation in Alzheimer's disease and delirium 280
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 279
Atypical parkinsonism and intrathecal anti-glutamic acid decarboxylase antibodies - An unusual association: A case report 279
Generation and validation of algorithms to identify subjects with dementia using administrative data 276
Donepezil modulates the endogenous immune response: implications for Alzheimer's disease 269
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 268
Glutamatergic Homeostasis Impairment in Multiple Sclerosis Patients 266
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 265
Malattie del Sistema Nervoso 264
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 264
Reduced platelet glutamate uptake in Parkinson's disease 261
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 260
Guillain-Barré syndrome related to COVID-19 infection 260
Multicentre translational Trial of Remote Ischaemic Conditioning in Acute Ischaemic Stroke (TRICS): protocol of multicentre, parallel group, randomised, preclinical trial in female and male rat and mouse from the Italian Stroke Organization (ISO) Basic Science network 260
Beta-amyloid-induced peripheral chemotactic response: what role in Alzheimer’s disease? 258
Inefficient skeletal muscle oxidative function flanks impaired motor neuron recruitment in Amyotrophic Lateral Sclerosis during exercise 258
Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease 257
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 256
Mutual Information Optimization for Mass Spectra Data Alignment 255
Adherence to recommendations and clinical outcomes of patients hospitalized for stroke: the role of the admission ward—a real-life investigation from Italy 252
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 252
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 248
Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation 242
Peripheral cytokine release in Alzheimer patients: Correlation with disease severity 240
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 240
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 239
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy 238
Behavioural anomalies in neurodegenerative diseases: role of the immune response 235
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 235
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 233
Diazepam binding inhibitor and dehydroepiandrosterone sulphate plasma levels in borderline personality disorder adolescents. 233
Primary Whipple disease of the Central Nervous System presenting with rhombencephalitis 232
Micrornas in als: from molecular mechanisms to clinical relevance 231
Nonfibrillar Abeta 1-42 inhibits glutamate uptake and phosphorylates p38 in human fibroblasts 228
Benzodiazepine receptors and diazepam-binding inhibitor in human cerebral tumors 226
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 225
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 225
Intracranial collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 225
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 225
Cerebellar hematoma in a carrier of the A3243G MELAS mutation 224
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 223
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 221
Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer's disease 221
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 221
Degenerazione Cortico-Basale: cos’è “corticale” e cosa “basale”? 218
Validation of the Italian version of the ALS cognitive-behavioral screen (ALS-CBS): preliminary results 217
Posterior reversible encephalopathy syndrome (PRES) associated with acute pancreatitis 217
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 217
Case Report: Concomitant Massive Cerebral Venous Thrombosis and Internal Iliac Vein Thrombosis Related to Paucisymptomatic COVID-19 Infection 217
Neuroligand binding endophenotypes in blood cells distinguish two subsets of borderline personality disorder patients 216
An unusual transthyretin gene missense mutation (TTR Phe33Val) linked to familial amyloidotic polyneuropathy 215
Alterede miRNA in Amyotrophic Lateral Sclerosis: Searching for the Lowest Common Multiple 215
Novel neurofibromatosis type 2 mutation presenting with status epilepticus 215
Idiopathic infratentorial superficial siderosis of the central nervous system: case report and review of literature 215
Who is really blind in the time of coronavirus: the patient or the doctor? A rare case of Balint’s syndrome 215
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 214
ALS mimics due to affection of the cervical spine: From common compressive myelopathy to rare CSF epidural collection 214
Prognostic Value of Signal Abnormalities on Brain MRI in Post-Anoxic Super-Refractory Status Epilepticus: A Single-Center Retrospective Study 214
High-dose atorvastatin after stroke or transient ischemic attack 213
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease 213
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 213
Totale 29.947
Categoria #
all - tutte 317.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 317.341


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219.813 692 459 1.051 1.051 739 702 967 763 883 1.049 561 896
2021/20226.886 636 684 879 606 489 564 290 327 356 420 561 1.074
2022/202311.884 1.308 3.449 1.029 1.224 814 1.758 163 642 834 113 330 220
2023/20248.692 308 302 443 447 1.080 2.142 1.569 365 546 205 246 1.039
2024/202522.272 1.140 2.268 1.206 852 1.689 1.270 1.237 844 1.997 3.129 2.102 4.538
2025/20264.637 4.637 0 0 0 0 0 0 0 0 0 0 0
Totale 93.908